期刊文献+

北京地区反流性食管炎患者幽门螺杆菌感染率调查 被引量:3

An Investigation about the Ratio of the Helicobacter Pylori Infection of Patients with Reflux Esophagitis in Beijing
原文传递
导出
摘要 目的调查近3年来北京地区反流性食管炎患者幽门螺杆菌(Hp)感染率,分析目前反流性食管炎与Hp感染的相关性。方法选择反流性食管炎患者119例和正常对照组121例,以快速尿素酶试验及13C-尿素呼气试验检测Hp感染。结果反流性食管炎患者Hp感染率(26.89%),显著低于对照组(42.15%),P<0.05。结论Hp可能在反流性食管炎的发病中起到保护作用。 Objective To investigate the ratio of the helicobecter pylori(Hp) infection of patients with reflux esophagitis(RE) in Beijing and study the relationship between RE and Hp. Methods 119 patients with RE and 121 controls were enrolled for the study. 3 biopsy specimens obtained from the gastric antrum for rapid urease test,at the same time ^13C-rapid urea breath test(13C-UBT) was used for everyone,Hp infection was affirmed when the two tests were positive. Results The ratio of the Hp infection found in the patients with RE was 26. 89% ,which was lower than the ratio of the controls,42. 15%, P 〈 0. 05. Conclusion Hp may give some protection to RE.
出处 《临床消化病杂志》 2007年第1期43-44,共2页 Chinese Journal of Clinical Gastroenterology
关键词 反流性食管炎 幽门螺杆菌 Reflux esophagitis(RE) Helicobecter pylori(Hp)
  • 相关文献

参考文献8

  • 1吴道宏,蔡昌豪.胃食管反流病食管测压的研究[J].世界华人消化杂志,2000,8(7):793-794. 被引量:8
  • 2朱春兰,徐晓红,孙晓梅.反流性食管炎的药物治疗[J].世界华人消化杂志,2000,8(10):1133-1134. 被引量:15
  • 3METZ DC,KROSER JA.Helicobacter pylori and gastroesophageal reflux disease[J].Gastroenterol Clin North Amer,1999,28:971.
  • 4FALLONE CA,BARKUN AN,FRIEDMAN G,et al.Is Helicobacter pylori eradication associated with gastroesophageal reflux disease[J].Am J Gastroenterol,2000,95:914.
  • 5WESTON AP,BADR AS,TOPALVSKI M,et al.Prospective evaluation of the prevalence of gastric helicobacter pylori infection in patients with GERD,Barrett esophagus,Barrett dysplasia,and Barrett adenocarcinoma[J].Am J Gastroenterol,2000,95:387.
  • 6WU JC,Sung JJ,Chan FK,et al.Helicobacter pylori infection is associated with milder gastro-csophagcal reflux discases[J].Aliment Pharmacol Ther,2000,14:427.
  • 7CSCNDES A,SMOK G,CCRDA G,et al.Prevalence of helicobacter pylori infection on 190 control and in 263 patients with gastroesophageal reflux,erosive esophagitis,and Barrett's esophagus[J].Dis Esophagus,1997,10:38.
  • 8ABBAS Z,FAREED R,BAIG MN,et al.Prevalence of histological reflux esophagitis in helicobacter pylori positive patients:effect of density of H.pylori and activity of inflammation[J].J Pak Med Assoc,2001,51:36.

二级参考文献11

  • 1[1]Armstrong D,Bennett JR,Blum AL,Dent J,Dombal MD,Galmiche JP,Lundell L,Margulies M,Richter E,Spechler SJ,Tytgat GNJ,Wallin L.The endoscopic assessment of esophagitis:a progress report on observer agreement.Gastroenterology,1996;111:85-92
  • 2[2]Soga T,Matsuura M,Kodama Y,Fujita T,Sekimoto I,Nishimura K,Yoshida S,Kutsumi H,Fujimoto S.Is a proton pump inhibitor necessary for the treatment of lower-grade reflux esophagitis? J Gastroenterol,1999;34:435-440
  • 3[3]Escourrou J,Deprez P,Saaggioro A,Geldof H,Fischer R,Maier C.Maintenance therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitis.Aliment Pharmacol Ther,1999;13:1481-1491
  • 4[4]Festen HP,Schenk E,Tan G,Snel P,Nelis F.Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease:short-and long-term treatment.The Dutch Reflux Study Group.Am J Gastroenterol,1999;94:931-936
  • 5[6]Gallo S,Dibildox M,Moguel A,Di Silvio M,Rodriguez F,Almaguer I,Garcia C.Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade Ⅱ and Ⅲ.A prospective,double-blind,double-placebo study.Mexican clinical experience.Mexican Pantoprazole Study Group.Rev Gastroenterol Mex,1998;63:11-16
  • 6[8]Wurzer H,Schutze K,Bethke T,Fischer R,Luhmann R,Riesenhuber C.Efficacy and safety of pantoprazole in patients with gastroesophaageal reflux disease using an intravenous-oral regimen.Austrian Intravenous Pantoprazole Study Group.Hepatogastroenterology,1999;46:1809-1815
  • 7[9]Schenk BE,Kuipers EJ,Klinkenberg-knol EC,Eskes SA,Meuwissen SG.Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease.Am J Gastroenterol,1999;94:884-887
  • 8[10]Van Rensburg CJ,Honiball PJ,Van Zyl JH,Grundling HD,Eloff FP,Spies SK,Simjee AE,Theron I,Fischer R,Louw JA.Safety and efficacy of pantoprazole 40 mg daily as relapse prophylaxis in patients with healed reflux oesophagitis-a 2-year follow-up.Aliment Pharmacol Ther,1999;13:1023-1028
  • 9隋瑞林,许国铭,邹多武.食管测压对反流性食管炎的诊断价值[J].新消化病学杂志,1997,5(1):33-34. 被引量:9
  • 10赵荣莱.胃食管反流性疾病的药物治疗[J].华人消化杂志,1998,6(2):153-154. 被引量:5

共引文献18

同被引文献34

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部